The use of Sildenafil in Neonates with Down Syndrome to Reduce Pulmonary Vascular Resistance.
Latest Information Update: 17 Nov 2023
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- Acronyms T21 Trial
- 12 Nov 2023 Status changed from not stated to discontinued.
- 10 Nov 2021 New trial record